Repligen Corp. buy Wolfe Research
Start price
29.04.25
/
50%
€123.75
Target price
29.04.26
€140.48
Performance (%)
-9.82%
Price
25.02.26
€112.00
Summary
This prediction is currently active. With a performance of -9.82%, the BUY prediction for Repligen Corp. by Wolfe_Research is down slightly. This prediction currently runs until 29.04.26. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Repligen Corp. | -2.820% | -2.820% |
| iShares Core DAX® | 0.048% | 1.311% |
| iShares Nasdaq 100 | 1.601% | -0.902% |
| iShares Nikkei 225® | 3.057% | 12.947% |
| iShares S&P 500 | 0.820% | 0.703% |
Comments by Wolfe_Research for this prediction
In the thread Repligen Corp. diskutieren
Repligen Co. (NASDAQ: RGEN) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $160.00 price target on the stock.
Ratings data for RGEN provided by MarketBeat